<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>NOPR Community:</title>
  <link rel="alternate" href="http://nopr.niscpr.res.in/handle/123456789/60" />
  <subtitle />
  <id>http://nopr.niscpr.res.in/handle/123456789/60</id>
  <updated>2026-10-05T09:42:06Z</updated>
  <dc:date>2026-10-05T09:42:06Z</dc:date>
  <entry>
    <title>Benzothiazole analogues and their biological aspects: A Review</title>
    <link rel="alternate" href="http://nopr.niscpr.res.in/handle/123456789/58612" />
    <author>
      <name>Popli, Jyoti V</name>
    </author>
    <author>
      <name>Kumbhare, Manoj R</name>
    </author>
    <author>
      <name>Surana, Ajay R</name>
    </author>
    <author>
      <name>Bhalerao, Mrunal R</name>
    </author>
    <author>
      <name>Agrawal, Pranay A</name>
    </author>
    <id>http://nopr.niscpr.res.in/handle/123456789/58612</id>
    <updated>2021-12-15T11:17:09Z</updated>
    <published>2021-12-01T00:00:00Z</published>
    <summary type="text">Title: Benzothiazole analogues and their biological aspects: A Review
Authors: Popli, Jyoti V; Kumbhare, Manoj R; Surana, Ajay R; Bhalerao, Mrunal R; Agrawal, Pranay A
Abstract: Heterocyclic compounds analogues have attracted strong interest in medicinal chemistry due to their pharmacological&#xD;
properties. Benzothiazole belongs to the heterocyclic class of bicyclic compounds. It is a combination of two rings six membered&#xD;
and five membered and both the rings are responsible for the therapeutic activity. Different methods are used to synthesize&#xD;
benzothiazole compounds and have been found to have numerous biological activities like – anticancer, antimicrobial,&#xD;
anti-inflammatory, anti-leishmanial, antidiabetic activity. This review is mainly an attempt to present the work reported in literature&#xD;
on pharmacological activity of benzothiazole compounds.
Page(s): 1659-1669</summary>
    <dc:date>2021-12-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Crystal structure determination, molecular modeling and surface analysis studies of 2-(4,6-dihydropyren-3-yl)-1H-benzodimidazole</title>
    <link rel="alternate" href="http://nopr.niscpr.res.in/handle/123456789/58611" />
    <author>
      <name>Manickam, R</name>
    </author>
    <author>
      <name>Jagan, R</name>
    </author>
    <author>
      <name>Jagadeesan, G</name>
    </author>
    <author>
      <name>Srinivasan, G</name>
    </author>
    <id>http://nopr.niscpr.res.in/handle/123456789/58611</id>
    <updated>2021-12-15T11:11:23Z</updated>
    <published>2021-12-01T00:00:00Z</published>
    <summary type="text">Title: Crystal structure determination, molecular modeling and surface analysis studies of 2-(4,6-dihydropyren-3-yl)-1H-benzodimidazole
Authors: Manickam, R; Jagan, R; Jagadeesan, G; Srinivasan, G
Abstract: Benzoimidazole compound has been synthesized and structurally characterized by single crystal X-ray diffraction&#xD;
studies, molecular docking and Hirshfeld surface analysis. The title compound C23 H14 N2 crystallizes in the Orthorhombic&#xD;
crystal system with the crystallographic space group of Pna21 with cell parameters a = 9.4472(5)Å, b=9.0556(5)Å,&#xD;
c=18.3755(11)Å, V=1572.03(15)Å3 and Z=4. The structure exhibits various intra and intermolecular interactions of the type&#xD;
N-H...N. Molecular docking studies of benzoimidazole compound have been executed with Cancer Osaka Thyroid kinease&#xD;
target protein which shows high binding affinity. In addition to this, Hirshfeld surface computational analysis have been&#xD;
carried out to analysis the hydrogen bond interaction. The major intermolecular contacts contributing to the Hirshfeld&#xD;
surface are H...H, H...N and H...C, respectively.
Page(s): 1652-1658</summary>
    <dc:date>2021-12-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Synthesis, structure elucidation and antibacterial screening of some novel 1,3,4-oxadiazoline derivatives</title>
    <link rel="alternate" href="http://nopr.niscpr.res.in/handle/123456789/58610" />
    <author>
      <name>Arshad, Mohammad</name>
    </author>
    <author>
      <name>Beg, Md Amjad</name>
    </author>
    <author>
      <name>Bhat, Abdul R</name>
    </author>
    <author>
      <name>Athar, Fareeda</name>
    </author>
    <id>http://nopr.niscpr.res.in/handle/123456789/58610</id>
    <updated>2021-12-15T11:07:53Z</updated>
    <published>2021-12-01T00:00:00Z</published>
    <summary type="text">Title: Synthesis, structure elucidation and antibacterial screening of some novel 1,3,4-oxadiazoline derivatives
Authors: Arshad, Mohammad; Beg, Md Amjad; Bhat, Abdul R; Athar, Fareeda
Abstract: Anovel sequence of 1,3,4-oxadiazoline derivatives has been synthesized with an endeavour to explore their consequence&#xD;
on in vitro growth of microbes causing the microbial contagion. In vitro antimicrobial activity has been performed against&#xD;
the Escherichia coli (E. coli) and Proteus mirabilis (P. mirabilis) which are Gram-negative (Gram-ve) and Staphylococcus&#xD;
aureus (S. aureus) and Staphylococcus epidermidis (S. epidermis) which are Gram-positive (Gram+ve) by using disk&#xD;
diffusion method. The minimum inhibitory concentration (MIC) has been distinguished by employing the double dilution&#xD;
method. The result of percent inhibition area/µg of the compounds has been differentiated with the standard drug&#xD;
“Ciprofloxacin”. Several compounds portray excellent activity as compared to the standard drug Ciprofloxacin while some&#xD;
of them presented a considerable zone of inhibition. The evaluated compounds for cytotoxicity effects via Human&#xD;
hepatocellular carcinoma (HepG2) cell line by MTT-assay and findings reveal that the experimental compounds display a&#xD;
viability of ≥80% at 100 µM. In molecular docking studies, the 1,3,4-oxadiazoline derivatives demonstrate the ligandreceptor&#xD;
interaction with amino acids which exist on the active sites of the peptide deformylase and the 1,3,4-oxadiazoline&#xD;
derivatives exhibit their antibacterial potential as peptide deformylase inhibitors.
Page(s): 1636-1651</summary>
    <dc:date>2021-12-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Synthesis, crystal structure and fluorescence spectrum of some new 1,2,3-triazolxanthen-3-one derivatives</title>
    <link rel="alternate" href="http://nopr.niscpr.res.in/handle/123456789/58609" />
    <author>
      <name>Dong, Hong-Ru</name>
    </author>
    <author>
      <name>Jin, Chi-Qiong</name>
    </author>
    <author>
      <name>Chen, Zi-Bao</name>
    </author>
    <id>http://nopr.niscpr.res.in/handle/123456789/58609</id>
    <updated>2021-12-15T10:44:07Z</updated>
    <published>2021-12-01T00:00:00Z</published>
    <summary type="text">Title: Synthesis, crystal structure and fluorescence spectrum of some new 1,2,3-triazolxanthen-3-one derivatives
Authors: Dong, Hong-Ru; Jin, Chi-Qiong; Chen, Zi-Bao
Abstract: Some new compounds 9-(1-aryl-5-methyl-1H-1,2,3-triazol-4-yl)-6-hydroxy-3H-xanthen-3-one 7a-j have been&#xD;
synthesized for new fluorescence probe material. Their fluorescence and ultraviolet-visible spectra have been studied. Their&#xD;
structures are established by MS, IR and 1H NMR spectral data. The structure of title compound 7c has been identified by&#xD;
X-ray diffraction. C22H14C1N3O3, belongs to triclinic system, space group Pī with a = 8.296(4), b = 9.726(5), c = 11.976(6)&#xD;
Å, α = 90.953(7), β = 105.081(7), γ = 100.693(8)º, V = 914.7(8)Å3, Z = 2, Dc = 1.466 Mg/m3, F(000) = 416.0 and μ = 0.240&#xD;
mm–1. The title compound has a weaker inhibiting HIV-1 protease than indinavir.
Page(s): 1629-1635</summary>
    <dc:date>2021-12-01T00:00:00Z</dc:date>
  </entry>
</feed>

